Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 100,000 shares at $125.90 ($12.6M) on 2022-11-30, disclosed to the SEC on 2022-12-01.
Open-market sale of $12.6M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.90 | 7,775 | $979K | 7.8% |
| 2 | $125.90 | 7,775 | $979K | 7.8% |
| 3 | $125.90 | 20,063 | $2.5M | 20.1% |
| 4 | $125.90 | 20,063 | $2.5M | 20.1% |
| 5 | $125.90 | 22,162 | $2.8M | 22.2% |
| 6 | $125.90 | 22,162 |
| $2.8M |
| 22.2% |
| Total | $125.90 avg | 100,000 | $12.6M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |